-
1
Downregulated METTL3 Accumulates TERT Expression that Promote the Progression of Ovarian Endometriosis
Published 2024-12-01Subjects: Get full text
Article -
2
METTL3 inhibits primed-to-naïve transition of pluripotent stem cells through m6A-YTHDF2-pluripotency/Gstp1 mRNA degradation axis
Published 2025-05-01Subjects: Get full text
Article -
3
Phosphodiesterase 1A physically interacts with YTHDF2 and reinforces the progression of non-small cell lung cancer
Published 2025-07-01Subjects: Get full text
Article -
4
YTHDF2 mediates the protective effects of MG53 on myocardial infarction injury via recognizing the m6A modification of MG53
Published 2025-02-01Subjects: Get full text
Article -
5
Pleckstrin-2 promotes the progression of colorectal cancer via YTHDF2-mediated TYMS mRNA stability
Published 2025-07-01Subjects: Get full text
Article -
6
-
7
YTHDF2 regulates the adriamycin (ADM) resistance in NKTCL by modulating the m6A modification of SLC16A9
Published 2025-09-01Subjects: Get full text
Article -
8
The m6A reader YTHDF2 protects vascular smooth muscle cells against the osteogenic differentiation through targeting Runx2
Published 2025-12-01Subjects: Get full text
Article -
9
-
10
YTHDF2 influences hepatic fibrosis by regulating ferroptosis in hepatic stellate cells by mediating the expression of ACSL4 in an m<sup>6</s...
Published 2024-12-01Subjects: “…YTHDF2…”
Get full text
Article -
11
METTL3 regulates Ambra1 expression in an m6A-YTHDF2-dependent manner to promote mantle cell lymphoma progression
Published 2025-07-01Subjects: Get full text
Article -
12
H3K18 lactylation-mediated Ythdf2 activation restrains mouse female germline stem cell proliferation via promoting Ets1 mRNA degradation
Published 2025-05-01Subjects: Get full text
Article -
13
Endogenous peptide CBDP1 inhibits clear cell renal cell carcinoma progression by targeting USP5/YTHDF2/TRPM5 axis
Published 2025-01-01Subjects: Get full text
Article -
14
New perspectives on YTHDF2 O-GlcNAc modification in the pathogenesis of intervertebral disc degeneration
Published 2024-10-01Subjects: Get full text
Article -
15
Targeting METTL3 as a checkpoint to enhance T cells for tumour immunotherapy
Published 2024-11-01Subjects: Get full text
Article -
16
Targeting YTHDF2 with pH-responsive siRNA nanoparticles suppresses MYC m6A modification and restores antitumor immunity in hepatocellular carcinoma
Published 2025-07-01Subjects: Get full text
Article -
17
N6-methyladenosine binding protein YTHDF2 inhibits gastric cancer cell growth and predicts better prognosis in patients with gastric cancer
Published 2025-06-01Subjects: “…YTH N6-methyladenosine RNA binding protein 2 (YTHDF2)…”
Get full text
Article